Could corticosteroid use put your patients at a greater risk of metabolic syndrome?
Mark L. Fuerst
Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.
Studies include drug-free remission of T2DM, and the impact of hyperglycemia and hypoglycemia on cardiovascular health.
A new set of guidelines will help people with type 1 diabetes mellitus exercise safely to avoid fluctuations in blood sugar.
Strength training can improve glycemic control among diabetics, but can it reduce rates of type 2 diabetes and cardiovascular disease?
March news includes a possible biomarker for diabetes, a new sensor to read glucose levels, and a study on insulin resistance and bone fracture.
In a randomized controlled trial, 24 men and women with pre-diabetes were assigned to either a diet high in protein or high in carbohydrate.
New studies review updated guidelines for metformin use, an examination of all-cause mortality in T2DM, and continuous glucose monitoring for T1DM.
This month’s roundup covers hip fracture risk, improvements in diabetes-associated risk assessment, and a model to calculate gestational diabetes risk.
How do you treat patients with type 2 diabetes unable to achieve glycemic control with either oral treatment or basal insulin?